Development of an Improved Oral Tablet Formulation of BNC210, a Negative Allosteric Modulator of the Alpha 7 Nicotinic Acetylcholine Receptor, Suitable for Evaluation as an Acute Treatment for Social Anxiety Disorder
NEUROPSYCHOPHARMACOLOGY（2022）
关键词
Social Anxiety Disorder, Acute Treatment, Phase II, Clinical Trial, BNC210
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要